It can be extrapolated that POCU1b may act as an anti-obesity agent by inhibiting pancreatic lipase and mediating cAMP-dependent PDE inhibition, leading to reduced perilipin and ADRP levels. This evidence concerns the gene PLIN2 and obesity due to melanocortin 4 receptor deficiency.